InvestorsHub Logo
Followers 971
Posts 383037
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Monday, 10/23/2023 11:49:19 AM

Monday, October 23, 2023 11:49:19 AM

Post# of 118383
"We know our shareholders are anxious to hear about our results surrounding modifying NR2F6 levels in CAR T-cells and we will get this data out as soon as we can," says Dr. David Koos, Chairman and CEO of the company.
Bullish
Bullish